XPeng (NYSE:XPEV – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Tuesday, November 19th. XPeng has set its Q3 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
XPeng (NYSE:XPEV – Get Free Report) last posted its earnings results on Tuesday, August 20th. The company reported ($0.19) earnings per share (EPS) for the quarter. XPeng had a negative return on equity of 23.38% and a negative net margin of 21.64%. The firm had revenue of $1.12 billion during the quarter. On average, analysts expect XPeng to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
XPeng Trading Up 0.9 %
Shares of XPEV stock opened at $12.74 on Monday. The company has a market capitalization of $12.00 billion, a PE ratio of -10.44 and a beta of 2.80. XPeng has a 52-week low of $6.55 and a 52-week high of $18.74. The business’s fifty day moving average is $11.44 and its 200 day moving average is $9.17. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.31 and a current ratio of 1.50.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on XPeng
XPeng Company Profile
XPeng Inc designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. It offers SUVs under the G3, G3i, and G9 names; four-door sports sedans under the P7 and P7i names; and family sedans under the P5 name. The company also provides sales contracts, super charging, maintenance, technical support, auto financing, insurance, technology support, ride-hailing, automotive loan referral, and other services, as well as vehicle leasing and insurance agency services.
Recommended Stories
- Five stocks we like better than XPeng
- The Significance of Brokerage Rankings in Stock Selection
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Utilities Stocks Explained – How and Why to Invest in Utilities
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- How to Read Stock Charts for Beginners
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for XPeng Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPeng and related companies with MarketBeat.com's FREE daily email newsletter.